High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
136 Downloads (Pure)
Original languageEnglish
JournalRheumatology
Early online date13 Aug 2018
DOIs
Publication statusE-pub ahead of print - 13 Aug 2018

Keywords

  • anti-PD-1
  • anti-PD-L1
  • pembrolizumab
  • melanoma
  • immune-related adverse event
  • arthritis

Cite this